- $157.15m
- $100.96m
- $0.10m
Annual balance sheet for Adagene, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 75.2 | 174 | 144 | 110 | 85.2 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.132 | 7.51 | 0.619 | 0.222 | 0.008 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 79.1 | 186 | 149 | 113 | 87.8 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.07 | 3.49 | 2.97 | 2.2 | 1.41 |
| Other Long Term Assets | |||||
| Total Assets | 84.3 | 190 | 152 | 116 | 89.3 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 16.1 | 29.8 | 55.1 | 31.5 | 38.2 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 19.2 | 33 | 69.3 | 45.2 | 38.7 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 65.1 | 157 | 83.1 | 70.6 | 50.5 |
| Total Liabilities & Shareholders' Equity | 84.3 | 190 | 152 | 116 | 89.3 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |